{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:45:24Z","timestamp":1777279524439,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107781","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:53:21Z","timestamp":1777276401000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Apelin in Type II Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Mahima","family":"Mehra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravada R","family":"Hemanth Sai Sri Harsha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-019-1450-4","article-title":"Diabetes mellitus - definition, classification, diagnosis, screening and prevention (update 2019) (Article in German)","volume":"131","author":"Harreiter J","year":"2019","unstructured":"Harreiter J, Roden M. Diabetes mellitus - definition, classification, diagnosis, screening and prevention (update 2019) (Article in German). Wien Klin Wochenschr. 2019, 131:6-15. 10.1007\/s00508-019-1450-4","journal-title":"Wien Klin Wochenschr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole JB","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020, 16:377-90. 10.1038\/s41581-020-0278-5","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108822","article-title":"Apelin\/APJ system in inflammation","volume":"109","author":"Wang X","year":"2022","unstructured":"Wang X, Zhang L, Li P, Zheng Y, Yang Y, Ji S. Apelin\/APJ system in inflammation. Int Immunopharmacol. 2022, 109:108822. 10.1016\/j.intimp.2022.108822","journal-title":"Int Immunopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.820002","article-title":"The role of apelin-APJ system in diabetes and obesity","volume":"13","author":"Li C","year":"2022","unstructured":"Li C, Cheng H, Adhikari BK, et al.. The role of apelin-APJ system in diabetes and obesity. Front Endocrinol (Lausanne). 2022, 13:820002. 10.3389\/fendo.2022.820002","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa M","year":"2020","unstructured":"Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020, 18:110-6. 10.2174\/1570161117666190405165151","journal-title":"Curr Vasc Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115268","article-title":"Therapeutic potential of apelin and Elabela in cardiovascular disease","volume":"166","author":"Gao S","year":"2023","unstructured":"Gao S, Chen H. Therapeutic potential of apelin and Elabela in cardiovascular disease. Biomed Pharmacother. 2023, 166:115268. 10.1016\/j.biopha.2023.115268","journal-title":"Biomed Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314680","article-title":"The protective role of apelin in the early stages of diabetic retinopathy","volume":"23","author":"Feng J","year":"2022","unstructured":"Feng J, Yang W, Luan F, et al.. The protective role of apelin in the early stages of diabetic retinopathy. Int J Mol Sci. 2022, 23:10.3390\/ijms232314680","journal-title":"Int J Mol Sci"},{"key":"ref8","article-title":"VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis","volume":"326","author":"Wu R","year":"2020","unstructured":"Wu R, Zhu Z, Zhou D. VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis. BMC Ophthalmology. 2020, 326:","journal-title":"BMC Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.11.027","article-title":"Relation between plasma apelin level and peripheral neuropathy in type 2 diabetic patients","volume":"13","author":"Hosny SS","year":"2019","unstructured":"Hosny SS, Nasr MS, Ibrahim RH, YousryHelal Z. Relation between plasma apelin level and peripheral neuropathy in type 2 diabetic patients. Diabetes Metab Syndr. 2019, 13:626-9. 10.1016\/j.dsx.2018.11.027","journal-title":"Diabetes Metab Syndr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.5008","article-title":"Apelin\u201113 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis","volume":"48","author":"Gao Z","year":"2021","unstructured":"Gao Z, Zhong X, Tan YX, Liu D. Apelin\u201113 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis. Int J Mol Med. 2021, 48:10.3892\/ijmm.2021.5008","journal-title":"Int J Mol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.414","article-title":"Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes","volume":"8","author":"Liu Y","year":"2017","unstructured":"Liu Y, Zhang J, Wang Y, Zeng X. Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes. Cell Death Dis. 2017, 8:e3006. 10.1038\/cddis.2017.414","journal-title":"Cell Death Dis"},{"key":"ref12","unstructured":"Human APLN (Apelin) ELISA kit (ELK4069). (2021). Accessed. April 23, 2026: https:\/\/www.elkbiotech.com\/pro\/ELK4069."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurger.2014.04.002","article-title":"Serum levels of apelin-36 are decreased in older hospitalized patients with heart failure","volume":"5(4)","author":"Basile G","year":"2014","unstructured":"Basile G, Crucitti A, Cucinotta MD, et al.. Serum levels of apelin-36 are decreased in older hospitalized patients with heart failure. Eur Geriatr Med. 2014, 5(4):242-5. 10.1016\/j.eurger.2014.04.002","journal-title":"Eur Geriatr Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher J","year":"2005","unstructured":"Boucher J, Masri B, Daviaud D, et al.. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005, 146:1764-71. 10.1210\/en.2004-1427","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.04.001","article-title":"Emerging roles of apelin in biology and medicine","volume":"107","author":"Kleinz MJ","year":"2005","unstructured":"Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005, 107:198-211. 10.1016\/j.pharmthera.2005.04.001","journal-title":"Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00490.2007","article-title":"HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes","volume":"293","author":"Glassford AJ","year":"2007","unstructured":"Glassford AJ, Yue P, Sheikh AY, et al.. HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab. 2007, 293:E1590-6. 10.1152\/ajpendo.00490.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054745","article-title":"The yin and yang effect of the apelinergic system in oxidative stress","volume":"24","author":"Fibbi B","year":"2023","unstructured":"Fibbi B, Marroncini G, Naldi L, Peri A. The yin and yang effect of the apelinergic system in oxidative stress. Int J Mol Sci. 2023, 24:10.3390\/ijms24054745","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485233-role-of-apelin-in-type-ii-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:53:24Z","timestamp":1777276404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485233-role-of-apelin-in-type-ii-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.107781","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}